Guerbet announces marketing authorisation approval of Elucirem™ (Gadopiclenol) in the European Union ...Middle East

PR Newswire - News
Guerbet announces marketing authorisation approval of Elucirem™ (Gadopiclenol) in the European Union
The marketing authorisation (MA) for Elucirem™ (Gadopiclenol) was granted to Guerbet by the European Commission based on the positive opinion of the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) dated 12 October 2023. For the indications approved in the...

Hence then, the article about guerbet announces marketing authorisation approval of elucirem gadopiclenol in the european union was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Guerbet announces marketing authorisation approval of Elucirem™ (Gadopiclenol) in the European Union )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News